Detalles de la búsqueda
1.
Characterization of cytoplasmic lipid droplets in each region of the small intestine of lean and diet-induced obese mice in response to dietary fat.
Am J Physiol Gastrointest Liver Physiol
; 321(1): G75-G86, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34009042
2.
Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes.
Biochim Biophys Acta
; 1861(8 Pt A): 730-47, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27108063
3.
The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus.
Bioorg Med Chem Lett
; 22(23): 7100-5, 2012 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23089526
4.
Diet Induced Obesity Alters Intestinal Cytoplasmic Lipid Droplet Morphology and Proteome in the Postprandial Response to Dietary Fat.
Front Physiol
; 10: 180, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30890954
5.
Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption.
Mol Metab
; 5(3): 210-220, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26977393
6.
Characterization of the proteome of cytoplasmic lipid droplets in mouse enterocytes after a dietary fat challenge.
PLoS One
; 10(5): e0126823, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25992653
7.
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats.
PLoS One
; 9(5): e97139, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24858947
8.
Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus.
J Med Chem
; 55(3): 1318-33, 2012 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-22196621
Resultados
1 -
8
de 8
1
Próxima >
>>